中文版 | English
Title

Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery

Author
Corresponding AuthorLiang,Shuli
Publication Years
2022
DOI
Source Title
ISSN
1756-2856
EISSN
1756-2864
Volume15
Abstract
Seizures are a common symptom of craniocerebral diseases, and epilepsy is one of the comorbidities of craniocerebral diseases. However, how to rationally use anti-seizure medications (ASMs) in the perioperative period of craniocerebral surgery to control or avoid seizures and reduce their associated harm is a problem. The China Association Against Epilepsy (CAAE) united with the Trauma Group of the Chinese Neurosurgery Society, Glioma Professional Committee of the Chinese Anti-Cancer Association, Neuro-Oncology Branch of the Chinese Neuroscience Society, and Neurotraumatic Group of Chinese Trauma Society, and selected experts for consultancy regarding outcomes from evidence-based medicine in domestic and foreign literature. These experts referred to the existing research evidence, drug characteristics, Chinese FDA-approved indications, and expert experience, and finished the current guideline on the application of ASMs during the perioperative period of craniocerebral surgery, aiming to guide relevant clinical practice. This guideline consists of six sections: application scope of guideline, concepts of craniocerebral surgery-related seizures and epilepsy, postoperative application of ASMs in patients without seizures before surgery, application of ASMs in patients with seizures associated with lesions before surgery, emergency treatment of postoperative seizures, and 16 recommendations.
Keywords
URL[Source Record]
Indexed By
Language
English
SUSTech Authorship
Others
Funding Project
Natural Science Foundation of Beijing Municipality[7202045];National Natural Science Foundation of China[82071488];
WOS Accession No
WOS:000842849700001
Scopus EID
2-s2.0-85136982848
Data Source
Scopus
Citation statistics
Cited Times [WOS]:0
Document TypeJournal Article
Identifierhttp://kc.sustech.edu.cn/handle/2SGJ60CL/401668
DepartmentShenzhen People's Hospital
Affiliation
1.Beijing Children’s Hospital,Capital Medical University,National Center for Children’s Health,Beijing,No. 56 Nanlishi Road, Xicheng District,100045,China
2.Beijing Neurosurgical Institute,Beijing Tiantan Hospital,Capital Medical University,Beijing,China
3.Xijing Hospital of Airforce Medical University,Xi’an,China
4.Nanfang Hospital,Southern Medical University,Guangzhou,China
5.Beijing Tiantan Hospital,Capital Medical University,Beijing,China
6.Xiangya Hospital,Central South University,Changsha,China
7.Sanbo Brain Hospital,Capital Medical University,Beijing,China
8.Beijing Tsinghua Changgung Hospital,Tsinghua University,Beijing,China
9.Tianjin Medical University General Hospital,Tianjin,China
10.Department of Neurosurgery,The First Affiliated Hospital,Xi’an Jiaotong University,Xi’an,China
11.Jiangsu Provincial People’s Hospital,Nanjing,China
12.Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan,China
13.The Affiliated Hospital,Jiangnan University,Wuxi,China
14.Shanghai General Hospital,Shanghai Jiaotong University School of Medicine,Shanghai,China
15.Shenzhen People’s Hospital (The Second Clinical Medical College,Jinan University,The First Affiliated Hospital,Southern University of Science and Technology,Shenzhen,China
16.General Hospital of Northern Theater Command,Shenyang,China
17.Shanghai Changzheng Hospital,Shanghai Neurosurgical Institute,Shanghai,China
18.Peking Union Medical College Hospital,Beijing,China
19.The First Affiliated Hospital,Hainan Medical University,Haikou,China
20.Shanxi Provincial People’s Hospital,Taiyuan,China
21.Peking University First Hospital,Beijing,China
22.Children’s Hospital of Fudan University,Shanghai,China
23.First Affiliated Hospital,Harbin Medical University,Harbin,China
24.Children’s Hospital of Soochow University,Suzhou,China
25.Department of Neurology,Qilu Hospital,Cheeloo College of Medicine,Shandong University,Jinan,China
26.Huashan Hospital,Fudan University,Shanghai,China
27.The Second Affiliated Hospital Zhejiang University School of Medicine,Hangzhou,China
28.The Second Hospital of Hebei Medical University,Shijiazhuang,China
29.The First Affiliated Hospital of Xinjiang Medical University,Urumqi,China
30.The First Affiliated Hospital of Fujian Medical University,Fuzhou,China
31.The Southwest Hospital,Army Medical University,Chongqing,China
32.Lanzhou University Second Hospital,Lanzhou,China
33.Department of Neurology,Qilu Hospital,Cheeloo College of Medicine,Shandong University,Jinan,China
34.The First Hospital of Jilin University,Changchun,China
35.Beijing Children’s Hospital,Capital Medical University,National Center for Children’s Health,Beijing,China
36.The First Affiliated Hospital of University of Science and Technology of China,Anhui Provincial Hospital,Hefei,China
37.Xuanwu Hospital,Capital Medical University,Beijing,China
38.West China Hospital,Sichuan University,Chengdu,China
39.China Association Against Epilepsy,Beijing,No. 135 Xizhimen Wai Avenue,100044,China
40.Beijing Neurosurgical Institute,Beijing Tiantan Hospital,Capital Medical University,Beijing,No. 119 South Fourth Ring West Road, Fengtai District,10070,China
41.Shanghai Changzheng Hospital,Shanghai Neurosurgical Institute,Shanghai,No. 415, Fengyan Road, Huangpu District,200003,China
42.Huashan Hospital,Fudan University,Shanghai,No. 12, Urumqi Middle Road, Jing’an District,200044,China
43.Institute of Epilepsy,Shandong University,Jinan,China
44.Key Laboratory of Major Disease in Children,Ministry of Education,Beijing,China
Recommended Citation
GB/T 7714
Liang,Shuli,Fan,Xing,Chen,Feng,et al. Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery[J]. Therapeutic Advances in Neurological Disorders,2022,15.
APA
Liang,Shuli.,Fan,Xing.,Chen,Feng.,Liu,Yonghong.,Qiu,Binghui.,...&Hong,Zhen.(2022).Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery.Therapeutic Advances in Neurological Disorders,15.
MLA
Liang,Shuli,et al."Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery".Therapeutic Advances in Neurological Disorders 15(2022).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Export to Excel
Export to Csv
Altmetrics Score
Google Scholar
Similar articles in Google Scholar
[Liang,Shuli]'s Articles
[Fan,Xing]'s Articles
[Chen,Feng]'s Articles
Baidu Scholar
Similar articles in Baidu Scholar
[Liang,Shuli]'s Articles
[Fan,Xing]'s Articles
[Chen,Feng]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Liang,Shuli]'s Articles
[Fan,Xing]'s Articles
[Chen,Feng]'s Articles
Terms of Use
No data!
Social Bookmark/Share
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.